The Lifelong Impact of X-Linked Hypophosphatemia: Results From a Burden of Disease Survey

CONTEXT: X-linked hypophosphatemia (XLH) is characterized by excess fibroblast growth factor 23 (FGF23), hypophosphatemia, skeletal abnormalities, and growth impairment. We aimed to understand the burden of disease of XLH across the lifespan. METHODS: Responses were collected from adults with XLH an...

Descripción completa

Detalles Bibliográficos
Autores principales: Skrinar, Alison, Dvorak-Ewell, Melita, Evins, Ayla, Macica, Carolyn, Linglart, Agnès, Imel, Erik A, Theodore-Oklota, Christina, San Martin, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595532/
https://www.ncbi.nlm.nih.gov/pubmed/31259293
http://dx.doi.org/10.1210/js.2018-00365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595532/
https://www.ncbi.nlm.nih.gov/pubmed/31259293
http://dx.doi.org/10.1210/js.2018-00365

Ejemplares similares